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SUMMARY
Components of the Fanconi anemia and homologous
recombination pathways play a vital role in protect-
ing newly replicated DNA from uncontrolled nucleo-
lytic degradation, safeguarding genome stability.
Here we report that histone methylation by the lysine
methyltransferase SETD1A is crucial for protecting
stalled replication forks from deleterious resection.
Depletion of SETD1A sensitizes cells to replication
stress and leads to uncontrolled DNA2-dependent
resection of damaged replication forks. The ability
of SETD1A to prevent degradation of these struc-
tures is mediated by its ability to catalyze methyl-
ation on Lys4 of histone H3 (H3K4) at replication
forks, which enhances FANCD2-dependent histone
chaperone activity. Suppressing H3K4 methylation
or expression of a chaperone-defective FANCD2
mutant leads to loss of RAD51 nucleofilament stabil-
ity and severe nucleolytic degradation of replication
forks. Our work identifies epigenetic modification
and histone mobility as critical regulatory mecha-
nisms in maintaining genome stability by restraining
nucleases from irreparably damaging stalled replica-
tion forks.
INTRODUCTION
To maintain genome stability during genome duplication,
numerous cellular pathways have evolved to detect and repair
structures and/or lesions that impair DNA replication. One key
response to compromised replication (known as replication
stress) involves the active reversal of stalled replication forks to
form 4-way DNA junctions. This represents a critical step in sta-
bilizing damaged forks (Neelsen and Lopes, 2015) and involves
homologous recombination (HR) factors such as RAD51 (Wang
et al., 2015; Zellweger et al., 2015). However, despite the impor-
tance of fork reversal in protecting genome stability, it is also
clear that the regressed arms of reversed forks are highly sus-
ceptible to nucleolytic degradation (Thangavel et al., 2015).
Although controlled processing of these structures can help to
maintain fork integrity and allow fork restart, uncontrolled degra-
dation of nascent DNA leads to severe genome instability (Quinet
et al., 2017).
Components of the Fanconi anemia (FA) and HR pathways,
including RAD51 (FANCR), FANCD2, BRCA1 (FANCS), and
BRCA2 (FANCD1), play a vital role in protecting nascent DNA
at reversed replication forks (Schlacher et al., 2011, 2012; So-
myajit et al., 2015; Ying et al., 2012; Zadorozhny et al., 2017).
Moreover, the deleterious resection of replication forks observed
in the absence of these factors can be prevented by limiting fork
reversal via depletion of ‘‘pro-reversal’’ factors; e.g., SMARCAL1
(Mijic et al., 2017; Taglialatela et al., 2017). However, despite
intensive study, the mechanisms by which cells protect nascent
DNA still remain poorly understood. It is imperative that we better
understand these processes because restoring fork protection in
tumor cells facilitates their ability to evade chemotherapy and
acquire drug resistance (Ray Chaudhuri et al., 2016).
Presently, it is unclear how reversed replication forks requiring
protection are marked; this may involve the presence of specific
factors, post-translational modification of the replication ma-
chinery and/or surrounding chromatin, and/or chromatin remod-
eling. In keeping with the premise that histone dynamics may
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Figure 1. BOD1L Acts with SETD1A to Maintain Genome Stability during Replication Stress
(A) HeLa nuclear cell extracts were subjected to immunoprecipitation with the denoted antibodies, and inputs and immunoprecipitates were analyzed by
immunoblotting. White lines denote removal of irrelevant lanes.
(B) HeLa cells were transfected with the indicated siRNAs for 72 hr and whole-cell extracts (WCEs) were analyzed by immunoblotting.
(legend continued on next page)
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play an important role in this process, members of the SNF2
family of remodeling ATPases promote fork degradation in the
absence of protective factors (Taglialatela et al., 2017). More-
over, the fork protection factor FANCD2 also remodels histones
at sites of replication stress (Sato et al., 2012). Interestingly,
several chromatin modifiers have also been implicated in pre-
venting fork degradation: the lysine methyltransferase (KMT)
EZH2 regulates recruitment of MUS81 to stalled forks (Rondinelli
et al., 2017), whereas the KMTs KMT2C/KMT2D (MLL2/3)
enhance MRE11-dependent fork processing (Ray Chaudhuri
et al., 2016). In contrast, the yeast KMT Set1, a component of
the evolutionarily conserved ‘‘complex proteins associated
with Set1p’’ (COMPASS) that catalyzes methylation of lysine 4
of histone H3 (H3K4), is required in the response to replication
stress (Faucher and Wellinger, 2010).
Recently, we identified BOD1L as a fork protection factor that
protects nascent DNA from degradation by DNA2 (Higgs et al.,
2015; Higgs and Stewart, 2016). Here we demonstrate that
BOD1L functionally interacts with the KMT SETD1A and that cells
lacking SETD1A phenocopy those depleted of BOD1L. Further-
more, we show that SETD1A methylates H3K4 at stalled replica-
tion forks,which facilitates themobilizationofhistonesbyFANCD2
and prevents replication fork degradation. Compromising H3K4
methylation abrogates FANCD2-dependent histone chaperone
activity, leads to fork degradation, andmimics the inability of cells
lacking SETD1A to recruit RAD51 to stalled forks. Our data there-
fore establish that SETD1A-dependent histone methylation and
subsequent histone remodeling protect stalled forks from uncon-
trolled processing, thereby maintaining genome stability.
RESULTS
BOD1L Interacts with SETD1A to Regulate Genome
Stability Following Replication Stress
We recently identified BOD1L as a factor that protects stalled
replication forks from degradation (Higgs et al., 2015). Previous
studies (van Nuland et al., 2013) have suggested that BOD1L
forms complexes with the KMTs SETD1A and SETD1B, two
closely related members of the KMT2 family that catalyze
H3K4 methylation (Bledau et al., 2014; Brici et al., 2017; Lee
and Skalnik, 2005; Lee et al., 2007). This suggested that SETD1A
and/or SETD1B may function with BOD1L to regulate replication
fork stability. We therefore first sought to confirm these interac-
tions before investigating any potential role of these enzymes in
fork protection. Interestingly, reciprocal immunoprecipitations
confirmed that BOD1L interacts with SETD1A, but not with
SETD1B, as was suggested previously (van Nuland et al.,
2013; Figure 1A).
The N-terminal region of BOD1L contains a region with
sequence homology to the Shg1 component of the yeast
COMPASS complex (Figure S1A) (PFAM: 05205; http://pfam.
xfam.org/family/PF05205) (Marchler-Bauer et al., 2011; Roguev
et al., 2001). We hypothesized that this ‘‘COMPASS-Shg1’’
domain may, by analogy, mediate the interaction of BOD1L
with the SETD1A complex. To assess this, we generated gluta-
thione S-transferase (GST)-tagged fragments of BOD1L span-
ning this domain or neighboring regions and analyzed their ability
to interact with SETD1A. These experiments revealed that a frag-
ment of BOD1L containing this COMPASS-Shg1 domain was
necessary and sufficient to mediate interaction with SETD1A
but not with SETD1B (Figure S1B).
To analyze the functional consequences of this interaction, we
depleted HeLa cells of BOD1L, SETD1A, or SETD1B, either
alone or in combination (Figure 1B), and exposed them to mito-
mycin C (MMC), which induces DNA interstrand crosslinks
(ICLs). Notably, depletion of SETD1A or BOD1L alone exquisitely
hypersensitized cells to MMC (Figure 1C). Moreover, cells lack-
ing SETD1A exhibited elevated chromosomal damage (Figures
1D, 1E, and S1C) and increased micronucleus formation after
treatment with MMC (Figure 1F), indicating a critical role for
this KMT in maintaining genome stability after replication dam-
age. In all cases, loss of SETD1A alone or alongside BOD1L
was comparable with BOD1L depletion, consistent with these
two factors residing within the same protein complex. In
contrast, depletion of SETD1B had no effect on cellular sensi-
tivity to replication stress (Figure 1), in keeping with our interac-
tion data, although we cannot completely exclude a role of this
enzyme in regulating genome stability. Moreover, cells lacking
SETD1A or BOD1L, but not SETD1B or BOD1 (a BOD1L pa-
ralog), were unable to suppress replication origin firing after
MMC exposure (Figure S1D), a characteristic of BOD1L defi-
ciency (Higgs et al., 2015). Together with our previous data
demonstrating that depletion of BOD1 had no effect on MMC
cellular sensitivity (Higgs et al., 2015), these observations are
consistent with a model in which BOD1L/SETD1A and BOD1/
SETD1B form functionally distinct KMT complexes.
SETD1A and BOD1L Suppress BLM/FBH1 to Stabilize
RAD51 and Prevent DNA2-Dependent Degradation of
Nascent DNA
Preventing aberrant replication fork resection is essential for
genome integrity during replication stress. The RAD51 recombi-
nase plays a crucial role in protecting stalled forks from such
degradation (Schlacher et al., 2011, 2012; Zadorozhny et al.,
2017; Zellweger et al., 2015); indeed, our previous studies
demonstrated that BOD1L suppresses degradation of stalled
replication forks by stabilizing RAD51 at these sites (Higgs
et al., 2015). To investigate whether SETD1A functioned in a
similar fashion, we first analyzed DNA resection in cells depleted
of BOD1L, SETD1A, or SETD1B, using phosphorylation of RPA2
(C) HeLa cells were transfected as above, exposed to the indicated doses of MMC, and left for 14 days, and colonies were stained with methylene blue and
counted.
(D and E) Cells from (C) were exposed to 50 ng/mLMMC for 20 hr and treated with colcemid for a further 4 hr. Chromosomal damage (D) and radial chromosome
formation (E) were enumerated by light microscopy after Giemsa staining. Representative images are shown in Figure S1.
(F) Cells from (C) were treated with MMC and left for 24 hr, and micronucleus formation was assessed by fluorescence microscopy.
(G) Cells from (C) were exposed to MMC for the indicated times, and WCE was analyzed by immunoblotting.
The plots in (C)–(E) represent mean data ± SEM from 3 independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S1.
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Figure 2. SETD1A Prevents Excessive ssDNA Formation after Replication Stress by Stabilizing RAD51
(A–C) HeLa cells were transfected with the indicated siRNAs for 72 hr; exposed to 50 ng/mLMMC for 24 hr; immunostained with antibodies to RPA2 (A), phospho-
RPA2 S4/S8 (B), or RAD51 (C). Focus formation was analyzed by fluorescence microscopy.
(D) Cells from (A) were exposed to 4 mM HU for 5 hr and immunostained with antibodies to RAD51, and focus formation was analyzed as above.
(E) Nuclear fluorescence intensity of cells from (A) was quantified using ImageJ. Lines denote mean values.
(F) Double-positive (RPA- and phospho-RPA2) cells from (A) and (B) were enumerated and are displayed as a percentage of total cells.
(legend continued on next page)
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on S4/S8 as a well-established marker of resected DNA. Inter-
estingly, levels of MMC-induced RPA2-P-S4/8 were substan-
tially elevated upon loss of BOD1L or SETD1A but not SETD1B
(Figures 1G, 2A, and 2B), consistent with increased generation
of single-stranded DNA (ssDNA). Moreover, similar to BOD1L,
SETD1A was required to recruit or stabilize RAD51 at stalled
forks upon exposure to either MMCor hydroxyurea (HU) (Figures
2C and 2D). Co-depletion of SETD1A and BOD1L had no addi-
tional effect on RPA/RPA2-P-S4/8 or RAD51 focus formation,
again suggesting that these factors act together (Figures 2B–
2G). Next, using 5-ethynyl-2’-deoxyuridine (EdU)-Click coupled
to proximity ligation (PLA) (Petruk et al., 2012; Taglialatela
et al., 2017), we analyzed whether the association of RAD51with
nascent DNAwas affected by loss of SETD1A. In agreement with
our previous data, SETD1A depletion significantly decreased the
levels of RAD51 on newly replicated DNA after HU exposure
(Figure 2H).
Given the importance of RAD51 in suppressing deleterious
fork processing, we next assessed whether SETD1A was
required to protect nascent DNA at replication forks. To this
end, we used a well-characterized fork protection assay
(Schlacher et al., 2011) to monitor the stability of nascent DNA
during prolonged replication arrest by HU. Loss of SETD1A,
but not SETD1B, increased the degradation of HU-stalled forks,
apparent as a decreased iododeoxyuridine (IdU):chlorodeoxyur-
idine (CldU) ratio (Figure 3A; Table S1), supporting our hypothe-
sis that SETD1A and SETD1B are functionally distinct. Moreover,
the fork degradation observed upon BOD1L loss was compara-
ble with that arising from SETD1A depletion (Figure 3B; Table
S1). Because fork remodeling enzymes such as SMARCAL1
catalyze fork reversal and, thus, provide a substrate for nucleo-
lytic degradation in the absence of protective factors (Kolinjivadi
et al., 2017), we investigated whether loss of SMARCAL1 sup-
pressed fork resection observed upon SETD1A loss. Indeed,
depletion of this annealing helicase reduced nascent strand
degradation in cells lacking SETD1A (Figure 3C; Table S1).
Together, this suggests that SETD1A-BOD1L prevent the resec-
tion of reversed replication forks.
Recent studies have suggested that other members of the
KMT2 family (KMT2C [MLL3] and KMT2D [MLL2]) promote
nascent strand degradation in the absence of BRCA2 (Ray
Chaudhuri et al., 2016). However, although we also observed
that depletion of KMT2C/KMT2D rescued fork stability in the
absence of BRCA2, this was not the case when these factors
were co-depleted in combination with SETD1A (Figures 3D–3F;
Table S1). Moreover, in stark contrast to cells lacking SETD1A,
loss of KMT2C/D alone had no effect on fork stability after HU.
These data reinforce the notion that different KMT2 enzymes
have diverse functions during replication stress.
Factors that regulate the stability of RAD51 filaments, such as
PARI, BLM, FBH1, and the RAD51 paralogs, also play vital roles
in maintaining replication fork stability (Mochizuki et al., 2017;
Somyajit et al., 2015). Previous work has demonstrated that
uncontrolled BLM/FBH1 activity can destabilize RAD51 nucleo-
filaments at stalled replication forks, leading to fork degradation
(Higgs et al., 2015; Higgs and Stewart, 2016; Leuzzi et al., 2016).
We therefore predicted that SETD1A may also counteract the
activities of these two anti-recombinases to stabilize RAD51 at
stalled forks. To investigate this, we co-depleted SETD1A and
BLM (Figure S2A), exposed the cells to MMC, and monitored
RPA S4/S8 phosphorylation and RAD51 focus formation. Strik-
ingly, loss of BLM reducedMMC-induced RPA S4/S8 phosphor-
ylation (Figure S2B) and restored HU- andMMC-induced RAD51
focus formation in the absence of SETD1A (Figures S2C and
S2D). Moreover, depletion of either FBH1 or BLM abrogated
the degradation of nascent DNA observed in cells lacking
SETD1A (Figure S2E; Table S1).
Because BOD1L, RAD51, and the FA pathway are crucial for
suppressing fork resection by DNA2 (Higgs et al., 2015; Karanja
et al., 2014; Liu et al., 2016), we assessed whether the over-
resection observed in the absence of SETD1A was dependent
on DNA2 or whether other nucleases implicated in fork resection
were also involved. In keeping with our previous observations in
cells lacking BOD1L (Higgs et al., 2015), co-depletion of DNA2,
but not EXO1 or MRE11, suppressed the degradation of HU-
stalled forks in the absence of SETD1A (Figure S2F; Table S1).
Therefore, SETD1A and BOD1L act together to stabilize
RAD51 on nascent DNA by restraining the anti-recombinase
functions of BLM/FBH1, protecting damaged replication forks
from DNA2-dependent resection.
The Catalytic Activity of SETD1A Is Required for Fork
Protection
Previous studies have demonstrated that the methyltransferase
activity of SETD1A toward H3K4 is mediated by its C-terminal
N-SET (COMPASS component N-Su(var)3-9, Enhancer-of-
zeste, Trithorax domain) and SET catalytic domains, whereas in-
teractions with WDR82, RNA, and RNA polymerase II (Pol II)
occur via the N-terminal RRM domain (Lee and Skalnik, 2008;
Luciano et al., 2017; Schlichter and Cairns, 2005). To examine
which of these domains is required for fork protection by
SETD1A, we established U-2-OS cell lines in which endogenous
SETD1A could be depleted with small interfering RNA (siRNA),
and either full-length (FL) FLAG-tagged SETD1A or variants lack-
ing the RRM (DRRM) or catalytic SET (DSET) domains could be
inducibly expressed (Figures S3A and S3B). Strikingly, the
genome instability (Figure 4A), defective RAD51 focus formation
(Figures 4B and 4C), and increased fork degradation (Figure 4D)
observed in the absence of endogenous SETD1A were all
restored following induced expression of FL and DRRM
SETD1A, but not the catalytically inactive DSET variant. This
suggests that the role for SETD1A in resolving replication
stress is independent of its ability to regulate transcription.
This contrasts with recent publications suggesting that SETD1A
(G) The mean percentage of cells from (C) and (D) exhibiting RAD51 foci was enumerated as above.
(H) Quantification of PLA signals between EdU andRAD51 in U-2-OS cells transfectedwith the indicated siRNAs.Where denoted, cells were exposed to 4mMHU
for 5 hr (as shown in the schematic). The mean ± SD of the number of biotin/biotin PLA signal-positive cells (below) indicates the number of S phase cells in each
condition.
The plots in (E)–(H) represent mean data ± SEM from 3 independent experiments. Scale bars, 10 mm. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S2.
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Figure 3. SETD1A Suppresses Fork Degradation after Replication Stress
(A–F) U-2-OS cells were transfected with control siRNA or those targeting: SETD1A and SETD1B (A); BOD1L and SETD1A (B); SETD1A and SMARCAL1 (C);
SETD1A and BRCA2 (D); SETD1A, BRCA2, and either KMT2C (E), or KMT2D (F). 72 hr post transfection, cells were pulsed for 20 min each with CldU and IdU and
exposed to 4 mMHU for 5 hr (as in the schematic). DNA was visualized with antibodies to CldU and IdU, and tract lengths were calculated. Plots denote average
ratios of IdU:CldU label length from 3 independent experiments; arrows indicate mean ratios. Plots in (E) and (F) amalgamate data from the same experiments.
See also Table S1.
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Figure 4. The KMT Activity of SETD1A Is Required to Protect Nascent DNA from Degradation
(A) U-2-OS cell lines bearing inducible full-length (FL) SETD1A or mutants lacking the RRM (DRRM) or N-SET and SET (DSET) domains were transfected with the
indicated siRNAs for 48 hr, exposed to 1 mg/mL doxycycline for 24 hr where denoted, and then exposed to 50 ng/mL MMC for a further 24 hr. Micronucleus
formation was quantified by fluorescence microscopy.
(legend continued on next page)
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functions within the DNA damage response (DDR) in hematopoi-
etic cells to regulate the transcription of a subset of DDR genes,
in part via association with CDK12/Cyclin K (Arndt et al., 2018;
Hoshii et al., 2018). To address this disparity, we therefore exam-
ined the protein levels of DDR genes identified to be deregulated
in the absence of SETD1A. These analyses revealed little or no
change in the expression of these DDR proteins upon SETD1A
depletion (Figure S3C). Moreover, and in support of a transcrip-
tion-independent role of SETD1A in regulating fork protection,
depletion of Cyclin K had no effect on nascent DNA degradation
of HU-stalled forks (Figures S3D and S3E) despite its apparent
role in SETD1A-dependent transcription (Hoshii et al., 2018).
Our findings therefore demonstrate that the catalytic methyl-
transferase activity of SETD1A is necessary for its role in fork
protection. Importantly, this function is unlikely to be mediated
through regulation of DDRgene transcription or via an interaction
with Cyclin K.
SETD1A Catalyzes H3K4 Methylation at Replication
Forks to Prevent Deleterious Fork Processing
Because the catalytic activity of SETD1A protects nascent DNA
from degradation, we next wanted to assess the effect of
depleting SETD1A or its closely related paralog, SETD1B, on
H3K4 methylation. Interestingly, depletion of these separate
KMT components from HeLa cells led to a significant, albeit
different, reduction in levels of global H3K4 mono-methylation
(H3K4me1), with depletion of SETD1A or SETD1B having effects
comparable with loss of BOD1L or BOD1, respectively (Fig-
ure 5A), a finding recapitulated in two independent DT40
BOD1L knockout clones (Figure S4A). These data suggest
that, although SETD1A and SETD1BKMT complexes both target
the same residue on histone H3, their loss has a differential effect
on total levels of H3K4 methylation.
Given our findings, we next investigated whether SETD1A
catalyzed H3K4 methylation specifically at stalled or reversed
replication forks during replication stress. We first used isolation
of proteins on nascent DNA (iPOND) coupled with mass spec-
trometry to assess protein abundance on newly replicated
DNA. This approach demonstrated that components present in
all KMT2 complexes (WDR5, RBBP5, and ASH2L) and those
only found in the SETD1A and SETD1B KMT complexes
(WDR82 and HCFC1) all associate with nascent DNA and HU-
stalled forks (Figure S4B). Moreover, SETD1A, but not SETD1B,
was also detected at these sites, albeit infrequently. We next
analyzed whether mono-methylated H3K4 at forks was affected
by replication stress or by loss of SETD1A or SETD1B using EdU-
PLA. This revealed that the association of H3K4me1 with
nascent DNA increased upon exposure to HU in a manner
dependent on SETD1A (Figure 5B). Importantly, this was not
due to any global changes in histone abundance after HU expo-
sure, since levels of H3 on nascent DNA were unaffected by
either HU or SETD1A loss (Figure S4C). Moreover, this effect
was specific to H3K4me1 because the levels of H3K4me3 at
similar sites were markedly less affected by SETD1A loss (Fig-
ure 5C). These data suggest that SETD1A catalyzes H3K4me1
at stalled replication forks.
To directly investigate the effect of H3K4 methylation on repli-
cation fork resection, we disrupted the balance of steady-state
methylation of H3K4 by creating stable HeLa cell lines express-
ing wild-type (WT) GFP-tagged histone H3.1 or a K4A mutant.
Expression of these variants in addition to endogenous H3.1
had no overt effects on cell cycle progression, regardless of
the presence of replication stress (Figure S4D). Next, we
exposed these cells to prolonged HU treatment and then as-
sayed for loss of fork protection. Strikingly, mutation of Lys4 of
H3 recapitulated the elevated fork degradation observed in cells
lacking BOD1L or SETD1A (Figure 5D). Notably, loss of SETD1A
in cells expressing the H3K4Amutant had no additional effect on
fork resection (Figure 5E), further reinforcing the hypothesis
that this KMT complex mediates fork protection via H3K4
methylation.
To analyze whether H3K4 methylation affected the stability
of RAD51 at stalled or damaged replication forks, we next
monitored RAD51 focus formation in these cells. Strikingly, the
formation of MMC- and HU-induced RAD51 foci was severely
compromised by expression of H3.1-GFP K4A but not by its
WT counterpart (Figures 5F and S4E). This was recapitulated in
two separate cell clones and could not be accounted for by
any alterations in RAD51 or H3-GFP protein expression (Fig-
ure S4F). Furthermore, expression of the K4A variant significantly
decreased the levels of RAD51 on nascent DNA after HU expo-
sure (Figure 5G), resulted in MMC hyper-sensitivity (Figure 5H),
and increased the levels of MMC-induced chromosomal dam-
age (Figures 5I andS4G). Consistent with a model in which
BOD1L, SETD1A, and H3K4 methylation act together to protect
RAD51 from the destabilizing activity of BLM, depletion of BLM
in cells expressing H3.1-GFP K4A restored RAD51 focus
formation (Figure S4H) and abrogated fork degradation (Fig-
ure S4I). Finally, depletion of DNA2 in cells expressing H3.1-
GFP K4A also restored fork stability (Figure S4J), in line with a
role for H3K4 methylation in preventing fork processing by this
exonuclease.
Together, these data suggest that the failure of cells lacking
SETD1A to stabilize RAD51 at stalled replication forks and the
subsequent inability to protect these structures from degrada-
tion are intimately linked to a defect in H3K4 methylation on
nascent DNA.
H3.1 Methylation Suppresses CHD4-Mediated Fork
Degradation
To investigate the mechanisms underlying methylation-depen-
dent fork protection, we first examined the involvement of
methyl-histone ‘‘reader’’ proteins. Members of the chromodo-
main helicase DNA-binding (CHD) family play important roles in
replication stress, and their activities or chromatin localization
are intimately linked with H3K4 methylation status. In particular,
(B and C) Cells from (A) were immunostained with antibodies to RAD51, and focus formation was analyzed by fluorescence microscopy (B). Representative
images are shown in (C). Scale bar, 20 mm.
(D) Cells from (A) were treated as described in Figure 3; arrows denote mean ratios.
Plots represent mean data ± SEM from 3 independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S3 and Table S1.
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Figure 5. SETD1A-Mediated H3K4 Methylation Is Required for Fork Protection
(A) HeLa cells were transfected with the indicated siRNAs for 72 hr, and WCEs were analyzed by immunoblotting.
(B and C) Quantification of PLA signals between EdU and H3K4me1 (B) or H3K4me3 (C) in U-2-OS cells transfected with the indicated siRNAs. Cells were
exposed to 4 mM HU for 5 hr where denoted.
(legend continued on next page)
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the H3K4 methyl-binding protein CHD1 is implicated in DNA
resection and RAD51 loading (Kari et al., 2016; Shenoy et al.,
2017; Sims et al., 2005), whereas the nucleosome remodeling
deacetylase (NuRD) component and tri-methylated lysine 9 of
histone H3 (H3K9me3) reader CHD4 is negatively regulated by
H3K4 methylation and promotes nascent DNA degradation in
BRCA2-deficient cells (Guillemette et al., 2015; Ray Chaudhuri
et al., 2016; Watson et al., 2012).
We therefore predicted that SETD1A-dependent fork protec-
tion may involve either of these remodelers. To examine this,
we co-depleted SETD1A and either CHD1 or CHD4 and exam-
ined the effect on ssDNA prevalence, RAD51 focus formation,
and replication fork and genome stability following exposure to
MMC. Interestingly, depletion of CHD4, but not CHD1, reduced
the elevated RPA focus formation observed upon SETD1A loss
(Figures S5A and S5B). However, abrogation of CHD4 expres-
sion in the absence of SETD1A did not restore RAD51 focus
formation (Figure 6A), suggesting that CHD4 does not act to
destabilize RAD51 nucleofilaments in the absence of H3K4
methylation. Nevertheless, depletion of CHD4 in cells lacking
SETD1A restored replication fork stability (Figures 6B and 6C),
rescued MMC hyper-sensitivity (Figure S5C), and reduced
MMC-induced genome instability (Figure 6D), consistent with a
role for CHD4 in promoting nascent strand degradation in the
absence of SETD1A. In keeping with the known role for H3K4
methylation in negatively regulating CHD4, loss of SETD1A
increased CHD4 localization on nascent DNA upon HU treat-
ment (Figure 6E), despite having no effect on H3K9me3 levels
at these sites (Figure S5D). In further support, depletion of
CHD4 (but not CHD1) from cells expressing H3.1-GFP K4A
also restored fork stability to normal levels (Figure S5E).
Together, these findings demonstrate that CHD4-mediated
fork degradation underlies the genome instability arising in cells
lacking SETD1A and that H3K4 methylation protects genome
stability in part by restricting the accessibility of CHD4 to
reversed forks.
The Histone Chaperone Activity of FANCD2 Acts
Downstream of Histone Methylation to Protect
Stalled Forks
It is well-established that FANCD2 playsmultiple roles in protect-
ing against replication stress, including the ability to suppress
DNA2-dependent degradation of nascent DNA in the absence
of BRCA1/2 (Kais et al., 2016; Karanja et al., 2014; Schlacher
et al., 2012). Given the functional overlap with SETD1A, and
because we have previously demonstrated that FANCD2
interacts with BOD1L (Higgs et al., 2015), we postulated that
BOD1L, SETD1A, and FANCD2 may function together. In agree-
ment, co-depletion of FANCD2 and SETD1A had no additional
effect on the extent of fork resection compared with loss of the
individual genes alone (Figure 7A; Table S1), and depletion of
BLM alleviated the fork resection observed in cells lacking
FANCD2 (Figure S6A; Table S1). Furthermore, loss of FANCD2
did not further increase nascent DNA degradation in cells ex-
pressing GFP-H3.1 K4A (Figure 7B). Together, this provides
strong evidence that SETD1A, H3K4 methylation, and FANCD2
function within the same pathway to prevent deleterious resec-
tion of stalled forks.
FANCD2 also possesses a histone chaperone activity that is
critical for ICL repair in vitro and in vivo (Sato et al., 2012). Given
the links between SETD1A, H3 methylation, and FANCD2, we
postulated that the BOD1L/SETD1A complex may also be
required for histone chaperoning upon replication stress. To
assess this, we depleted BOD1L, SETD1A, or SETD1B from cells
expressing WT H3.1-GFP and analyzed the mobility of GFP-
tagged H3.1 before and after MMC exposure using fluorescence
recovery after photobleaching (FRAP). Previous data demon-
strated that, in the absence of FANCD2, the recovery kinetics
of H3.1-GFP were perturbed specifically in the presence of repli-
cation stress (Sato et al., 2012). Strikingly, the mobility of H3.1-
GFP after MMC treatment was also impaired in the absence of
SETD1A or BOD1L (but not SETD1B) (Figure S6B) in a manner
similar to cells lacking FANCD2. Furthermore, co-depletion of
FANCD2 alongside either BOD1L or SETD1A had no significant
additional effect on H3.1-GFP mobility (Figures S6C and S6D),
suggesting that these three proteins function together to
remodel chromatin after replication stress. To assess whether
SETD1A and FANCD2 were specifically required for the mobility
of newly synthesized histones, we next made use of the SNAP-
tagged H3.1 system (Adam et al., 2013). These analyses re-
vealed that SETD1A and FANCD2 also promote the mobility or
deposition of new H3.1 histones after HU exposure (Figures 7C
and S6E).
Given that loss of BOD1L/SETD1A perturbs histone mobility,
we postulated that impaired H3K4me may also negatively affect
this process. We therefore analyzed histone mobility by FRAP in
cells expressing the H3.1-GFP K4A variant. When compared
with WT H3.1-GFP, mutation of Lys4 lead to impaired H3.1-
GFP mobility specifically after replication stress (Figures 7D
and S6F), a finding recapitulated in both cell clones (Figure S6G).
Together, these data suggest that H3K4 methylation promotes
H3mobility in the presence of replication damage. In agreement,
depletion of either BOD1L or SETD1A had no additional effect
on H3.1-GFP K4A mobility (Figure S6H), indicating that this
KMT complex promotes histone mobility through its ability to
methylate H3K4.
(D) Stable HeLa cells expressing WT H3.1-GFP or a K4A mutant (clone D1) were treated as described in Figure 3, and average IdU:CldU ratios were calculated
(denoted by an arrow).
(E) Cells from (D) were transfected with the indicated siRNAs and treated as above.
(F) Cells from (D) were exposed to 50 ng/mLMMC for 24 hr or 4 mMHU for 5 hr and immunostained with antibodies to RAD51, and focus formation was analyzed
by fluorescence microscopy. Scale bar, 20 mm.
(G) Quantification of PLA signals between EdU and RAD51 in cells from (D). Where denoted, cells were exposed to 4 mM HU for 5 hr.
(H) Cells from (D) were exposed to the indicated doses of MMC and left for 14 days, and colonies were stained with methylene blue and enumerated.
(I) Cells from (D) were exposed to 50 ng/mL MMC for 20 hr and treated with colcemid, and the incidence of chromosomal damage was analyzed by Giemsa
staining and light microscopy.
The plots in all cases represent mean data ± SEM from 3 independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S4 and Table S1.
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Figure 6. H3K4 Methylation by SETD1A Protects against CHD4-Mediated Fork Degradation
(A) U-2-OS cells were transfected with the indicated siRNAs for 72 hr, exposed to 50 ng/mL MMC for 24 hr, and immunostained with antibodies to RAD51, and
focus formation was analyzed by fluorescence microscopy. Representative images are shown (right). Scale bars, 10 mm.
(B and C) Cells were transfected with control siRNA or those targeting SETD1A and CHD1 (A) or SETD1A and CHD4 (B), exposed to HU, and treated as described
in Figure 3. Plots in (B) and (C) amalgamate data from the same experiments; arrows indicate mean ratios.
(legend continued on next page)
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Intriguingly, these data also suggest that stalled replication
forks may be protected from degradation by the chaperone ac-
tivity of FANCD2. To address this possibility, we made use of
DT40 cells expressing eitherWT chFANCD2, themono-ubiquity-
lation-deficient chFANCD2-K563R mutant, or the histone chap-
erone-defective mutant chFANCD2-R305W (Sato et al., 2012;
Figure S7A). We then compared the ability of these variants to
prevent fork degradation after prolonged HU treatment. Notably,
loss of the histone chaperone function of FANCD2 compromised
its ability to protect nascent DNA from processing (Figure 7E;
Table S1). Moreover, pharmacological inhibition of DNA2 (Liu
et al., 2016), but not MRE11, in cells expressing chFANCD2-
R305W restored fork stability (Table S1), suggesting that the
histone chaperone function of FANCD2 protects against
DNA2-dependent fork degradation. Finally, and in keeping with
a role for the histone chaperone activity of FANCD2 in promoting
RAD51-dependent fork protection, the destabilization of MMC-
induced RAD51 nucleofilaments in human cells lacking FANCD2
(measured by FRAP) (Sato et al., 2016) was not restored by
expression of the histone chaperone-defective R302W mutant
(Figures 7F and S7B).
To further delineate the link between the histone chaperone
activity of FANCD2 and H3K4 methylation, we examined
whether binding of FANCD2 to H3was affected by H3K4methyl-
ation or whether FANCD2 was necessary for SETD1A activity.
Interestingly, although loss of FANCD2 expression had no effect
on H3K4me1 levels (Figure S7C), we observed a small but repro-
ducible increase in the binding of FANCD2 (either from extracts
or using recombinant protein) to H3 peptides or proteins that
were mono-methylated on K4 (Figures S7D–S7G), suggesting
that H3K4me1 may modulate FANCD2 binding, albeit mildly. In
agreement, loss of SETD1A had a mild effect on the recruitment
of FANCD2 to damaged chromatin (Figure S7H), but not to
nascent DNA (Figure S7I). Althoughwe did not observe amarked
effect of H3K4me1 on FANCD2-histone binding, our data sug-
gest that this modification might, in part, facilitate recruitment
of FANCD2 to sites of replication stress.
Combined, our data demonstrate that, during replication
stress, H3K4 methylation by SETD1A protects replication forks
from over-resection by limiting CHD4 localization and by
enhancing FANCD2-dependent histone chaperone activity.
Subsequent histone mobility protects stalled replication forks
from degradation by promoting RAD51-dependent fork protec-
tion (Figure 7G). In the absence of H3K4 methylation or SETD1A,
histone mobility is reduced, destabilizing RAD51 at damaged
forks. These forks then undergo deleterious resection, partly
mediated via the unrestrained activity of CHD4, giving rise to se-
vere genome instability.
DISCUSSION
Although many factors required to stabilize damaged replication
forks have been identified, it remains to be determined how post-
translational modification of chromatin helps to govern this pro-
cess. Here we have demonstrated that the KMT SETD1A plays
an integral role in preventing degradation of nascent DNA at
reversed forks. Critically, we have shown that SETD1A-mediated
H3K4 methylation is required for this protection and for the sta-
bilization of RAD51 at reversed forks. As a consequence, cells
depleted of SETD1A or expressing a mutant of H3 unable to be
methylated on Lys4, fail to stabilize RAD51, are unable to protect
nascent DNA from degradation by DNA2, and exhibit increased
genome instability after exposure to replication stress. More-
over, because the fork degradation in cells lacking SETD1A or
expressing H3K4A can be rescued by depletion of the anti-
recombinase BLM, this strongly suggests that H3K4 methyl-
ation is inherently linked to maintaining RAD51 nucleofilament
stability.
SETD1A and SETD1B Are Functionally Distinct KMTs
Although the COMPASS KMT Set1 and histone H3K4 methyl-
ation have previously been linked to resistance to replication
stress in yeast (Faucher and Wellinger, 2010), the roles of the
mammalian COMPASS homologs SETD1A and SETD1B in this
process have so far not been examined. Here we demonstrate
that, although these two KMTs both target H3K4 for methylation,
only SETD1A is required to protect cells against replication
stress. Indeed, in contrast to loss of SETD1A, depletion of
SETD1B does not confer MMC hyper-sensitivity at the cellular
level and does not lead to replication fork instability (Figures 1,
2, and 3). This functional divergence is likely linked to their ability
to bind specific Shg1-like proteins, our data (Figures 1 and S1),
combinedwith previous analyses, strongly suggest that SETD1A
functionally interacts with BOD1L, whereas SETD1B interacts
with BOD1 (Hein et al., 2015; van Nuland et al., 2013). Moreover,
BOD1, like SETD1B, plays no discernible role in the cellular
response to replication stress (Higgs et al., 2015). This is in
agreement with a recent publication describing a functional
cytoplasmic SETD1B-BOD1 complex (Wang et al., 2017). Inter-
estingly, because BOD1 modulates the activity of specific PP2A
regulatory subunits at kinetochores during mitosis (Porter et al.,
2007; Porter et al., 2013), SETD1B-dependent histone methyl-
ation may also play a role in this process.
We speculate that, because both BOD1 and BOD1L contain a
COMPASS-Shg1 domain (Marchler-Bauer et al., 2011; van Nu-
land et al., 2013), which, in the case of BOD1L, likely mediates
its interaction with SETD1A (Figure S1B), it is these subunits of
the SET1-containing complexes that regulate the distribution
and/or function of the respective catalytic KMT. Because
BOD1L is a target for ataxia telangiectasia mutated/ATR-depen-
dent (ATM/ATR-dependent) phosphorylation (Matsuoka et al.,
2007), we hypothesize that such damage-induced modification
may modulate the recruitment and/or activity of the BOD1L/
SETD1A complex at stalled replication forks. In addition, our
data suggest that, despite their shared ability to methylate
H3K4, SETD1A and SETD1Bmay methylate chromatin at distinct
(D) Micronucleus formation in cells from (A) was analyzed by fluorescence microscopy.
(E) Quantification of PLA signals between EdU and RAD51 in U-2-OS cells transfected with the indicated siRNA. Where denoted, cells were exposed to 4 mM
HU for 5 hr.
In all cases, plots represent mean data ± SEM from 3 independent experiments. *p < 0.05 and ***p < 0.001. See also Figure S5 and Table S1.
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Figure 7. SETD1A and FANCD2 Promote H3 Mobility to Protect Fork Integrity
(A) U-2-OS cells were transfected with the indicated siRNAs and treated as in Figure 3. Arrows indicate mean ratios.
(B) Stable HeLa cells expressing WT H3.1-GFP or a K4A mutant (clone D1) were transfected with the indicated siRNAs and treated as above.
(C) U-2-OS cells from (A) were transfected with SNAP-tagged H3.1 and analyzed to reveal levels of pre-existing SNAP-H3.1 (Pulse), background fluorescence
(Quench-Pulse), and new H3.1 after a 2-hr release into HU (Quench-HU-Pulse). Cells were analyzed by fluorescence microscopy, and fluorescence intensity per
nucleus was quantified using ImageJ.
(legend continued on next page)
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environments or in response to different stimuli. In support of
this notion, SETD1A and SETD1B function in a non-redundant
manner during embryogenesis and the embryonic lethality result-
ing from loss of either KMT occur at different stages of develop-
ment (Bledau et al., 2014).
Mechanisms for Epigenetic Modifications in Regulating
Fork Stability
Our data, when combined with observations assessing the ef-
fect of the H3K27 KMT EZH2 (Rondinelli et al., 2017) and the
PTIP-containing MLL2/3 KMT complex (Ray Chaudhuri et al.,
2016) on replication fork stability, are consistent with the hy-
pothesis that epigenetic modifications control the recruitment
and/or activity of factors that regulate fork stability. In keeping
with this prediction, we demonstrate that H3K4 methylation
regulates the localization of the chromodomain helicase DNA-
binding protein CHD4 (Figure 6). Interestingly, our finding that
CHD4 loss prevents nascent DNA degradation in the absence
of SETD1A without restoring RAD51 recruitment (Figures 6A–
6C) in a manner similar to observations in BRCA2 mutant cells
(Guillemette et al., 2015; Ray Chaudhuri et al., 2016) suggests
that CHD4 may either promote replication fork reversal or
modulate the local chromatin environment to allow nucleases
access to the damaged fork. Although the precise contribution
of CHD4 to fork degradation in the context of SETD1A
deficiency remains to be elucidated, in cells lacking BRCA1/
2, this pro-resection activity of CHD4 occurs through dysre-
gulation of RAD18-dependent translesion synthesis (TLS). It
is currently unclear whether a similar mechanism occurs in
BOD1L/SETD1A-depleted cells.
In addition to SETD1A and SETD1B, the KMT2 family of
H3K4 methyltransferases also contains the myeloid/lymphoid
(MLL) subfamily of enzymes (KMT2A–KMT2D). Recent studies
have proposed a role for murine Mll3 and Mll4 (human
KMT2C [MLL3] and KMT2D [MLL2] respectively) in promoting
fork resection in the absence of BRCA2 (Ray Chaudhuri
et al., 2016). These studies suggested that H3K4 methylation
promotes fork degradation upon loss of BRCA1 or BRCA2 by
recruiting MRE11 to stalled or reversed forks. In contrast, we
have demonstrated that SETD1A-dependent H3K4 methylation
protects reversed forks from resection by promoting RAD51-
dependent fork stability. It is also clear that SETD1A depletion
does not promote nascent strand degradation in the absence
of BRCA2 and that it is functionally distinct from KMT2C/D (Fig-
ure 3). On face value, it is difficult to reconcile why different
KMT complexes targeting H3K4 would have opposing roles
at damaged replication forks. However, it is apparent that all
6 members of the KMT2 family of methyltransferases are not
functionally redundant (Bledau et al., 2014; Duncan et al.,
2015). Moreover, the timing, localization, and cellular context
of specific nucleosomes being targeted for H3K4 methylation
is likely to have very different outcomes. Interestingly, only
loss of SETD1A (and not SETD1B or KMT2C/D) on a WT ge-
netic background allows increased fork resection (Figure 3),
indicating a primary constitutive role for this KMT2 family
member in preventing fork degradation. In contrast, the enzy-
matic activity of the PTIP-associated methyltransferases
(KMT2C/D) only appears to be required when fork stability
has already been compromised; e.g., in the absence of
BRCA2 (Ray Chaudhuri et al., 2016; Figure 3).
Several hypotheses arise from these observations: first,
SETD1A may regulate multiple different processes required to
stabilize a damaged fork; for example, stabilizing RAD51 nucle-
ofilaments, suppressing anti-recombinase activity, and methyl-
ating H3 at reversed forks. Second, the context of the damaged
fork might dictate which KMT is utilized to modify the nascent
chromatin surrounding the fork. In this respect, it is conceivable
that SETD1A and KMT2C/D could target histone H3 within
different regions of the genome undergoing DNA replication
(Calo and Wysocka, 2013; Duncan et al., 2015) or differentially
methylate the histone variants H3.1 and H3.3 at damaged
forks, depending on the composition of the chromatin undergo-
ing replication; i.e., whether it is a transcriptionally active or inac-
tive region. Finally, specific epigenetic changes surrounding
damaged forks may dictate which KMT is recruited. For
example, H2B mono-ubiquitylation in yeast and humans by the
Bre1 or RNF20/40 ubiquitin ligases potentiates H3K4 methyl-
ation by promoting recruitment of the Set1-COMPASS com-
plexes via their Swd2 subunit (human WDR82) (Hung et al.,
2017; Wood et al., 2005; Wu et al., 2008). Because the MLL
KMT complexes lack WDR82 (van Nuland et al., 2013), H2B
mono-ubiquitylation would provide a high degree of specificity
and selectivity between the different KMT2 complexes. Further-
more, because the KMT2 complexes differ in their associated
cofactors, it is plausible that these complex-specific subunits
(e.g., BOD1L and PTIP) may bind alternative epigenetic marks
to convey further selectivity.
Methylation-Enhanced Nucleosome Mobility Is
Required for Fork Protection
For the first time, our findings illustrate that histone methylation
is intimately linked to nucleosome mobility at damaged forks
and that this is required to prevent degradation of nascent
DNA. At present, it is unclear how H3K4 methylation regulates
FANCD2-dependent histone chaperoning. It is possible that
SETD1A-dependent histone methylation may modulate the
(D) Stable HeLa cells expressing WT H3.1-GFP or a K4A mutant (clone D1) were left untreated or exposed to MMC for 24 hr and analyzed by FRAP.
(E) WT DT40 cells or FANCD2/ cells expressing the indicated GFP-tagged chFANCD2 variants were treated as described in Figure 3. Arrows indicate
mean ratios.
(F) Stable U-2-OS-GFP-RAD51 cells were co-transfected with the indicated siRNA and plasmids encoding either WT or chaperone-dead (R302W) mCherry-
FANCD2 and exposed to MMC, and the mobility of GFP-RAD51 was analyzed by FRAP.
(G) Model for the role of SET1A-dependent H3K4 methylation in protecting stalled replication forks. Upon fork reversal during replication stress, H3K4me1 by
SETD1A acts to restrict CHD4 localization and promote FANCD2-dependent histone mobility. This chaperone activity is vital to stabilize RAD51 nucleofilaments,
preventing nucleolytic degradation of stalled forks by DNA2.
The plots in (D) and (F) represent mean ± SD relative fluorescence intensities from n = 21–26 and 25–48 cells, respectively. *p < 0.05. See also Figures S6 and S7
and Table S1.
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accessibility of chromatin to FANCD2, allowing histones to be
mobilized. Alternatively, H3K4 methylation may promote the
recruitment and/or binding of co-factors vital to promote
FANCD2-dependent nucleosome remodeling. Nevertheless,
our working model places SETD1A-dependent H3K4 methyl-
ation as a major regulatory epigenetic modification that permits
FANCD2 to mobilize histones onto the regressed arm of a
reversed fork (Figure 7G), protecting the 30 end of the RAD51
nucleofilament from the anti-recombinase activities of BLM.
This is entirely in keeping with the finding that fork degradation
in cells lacking FANCD2 is restored by co-depletion of BLM
and that the histone chaperone activity of FANCD2 is required
for RAD51 nucleofilament stability (Figures 7 and S7). Further-
more, this model predicts that movement of histones onto or
near reversed forks is a vital mechanism to protect their integ-
rity and suggests that other factors able to promote histone
mobility in similar situations may also be involved in protecting
nascent DNA.
In summary, our findings reveal the importance of the methyl-
ation and subsequent mobility of histones in protecting nascent
DNA from nucleolytic degradation. Our data further reinforce the
notion that epigenetic modifications of chromatin surrounding
stalled forks play a critical role in governing the recruitment/
activity of pro- and anti-resection factors and highlight the
importance of context-dependent histone lysine methylation in
maintaining genome stability.
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DT40s (WT and FANCD2 variants) Minoru Takata; Sato et al., 2012 N/A
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SETD1A siRNA (30 UTR) QIAGEN Cat# SI05029045
SETD1A siRNA (SmartPool; SP) Dharmacon Cat# L-022793-01-0010
BOD1L siRNA (SP) Dharmacon Cat# L-017033-02-0005
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FBH1 siRNA (SP) Dharmacon Cat# J-017404-05-0005
BLM siRNA (SP) Dharmacon Cat# J-007287-06-0005
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Further information and requests for resources and reagents should be directed to, and will be fulfilled by, the Lead Contact, Profes-
sor Grant Stewart (g.s.stewart@bham.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture and Generation of Cell Lines
U-2-OS cells (ATCC) were cultured in McCoys 5A medium, supplemented with 10% FBS and penicillin/streptomycin. HeLa cells
(ATCC) were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf serum (FCS) (Life Technologies)
and penicillin/streptomycin.
U-2-OS-FLAG-SETD1A FL, DSET and DRRM inducible cell lines were generated by Flp recombinase–mediated integration using
U-2-OS-Flp-In T-REx host cells transfected with pcDNA5/FRT-FLAG-SETD1A FL, DSET or DRRM, together with pOG44. Trans-
fected cells were selected and expanded for testing, cultured as above in the presence of 10% Tet-free FBS (Lonza), and SETD1A
variant expression was induced with doxycycline (Sigma-Aldrich).
The generation of HeLa cells expressing both H3.1-GFPWT and mCherry-PCNA was described previously (Sato et al., 2012). The
HeLa cells expressing either H3.1-GFP K4A or WT H3.1-GFP were generated using PiggyBac Transposon Vector System (System
Biosciences). After cloning the H3.1-GFP K4A or WT H3.1-GFP sequence into PB533A-2 vector, the resulting plasmid was cotrans-
fected into HeLa cells with PiggyBac Transposase vector (PB210PA-1) using FuGene HD (Promega). The cells were then cultured in
1 mg/ml G418 (Nacalai Tesque) to select clones stably expressing either H3.1-GFP K4A or WT H3.1-GFP. The creation of stable
Continued
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BOD1 siRNA (SP) Dharmacon Cat# L-015526-02-0005
SETD1B siRNA (SP) Dharmacon Cat# J-027025-09-0005
CHD1 siRNA (SP) Dharmacon Cat# J-008529-05-0005
CHD4 siRNA (SP) Dharmacon Cat# L-009774-00-0005
KMT2B (MLL2) siRNA (SP) Dharmacon Cat# L-009670-00-0005
KMT2C (MLL3) siRNA (SP) Dharmacon Cat# L-007039-00-0005
BRCA2 siRNA (SP) Dharmacon Cat# L-003462-00-0005
MRE11 siRNA (SP) Dharmacon Cat# L-009271-00-0005
Cyclin K siRNA (SP) Dharmacon Cat# L-029590-00-0005
Control siRNA (luciferase) (CGUACGCGG
AAUACUUCGdTdT)
Dharmacon Cat# CTM-334043
Control siRNA (Negative Control Hi GC) Life Technologies Cat# 10317903
BOD1L F1 Fwd (TATCCTGTCGACATGG
CCACCAACCCACAGCCGCAG)
Sigma-Aldrich N/A
BOD1L F1 Rev (CGAGTTAGCGGCCGG
GGTTTCTTTGGAATCTTCTTCATA)
Sigma-Aldrich N/A
BOD1L F2 Fwd (CACGACGTCGACGAAA
AAGAAGAGAGGCTTTTAAGA)
Sigma-Aldrich N/A
BOD1L F2 Rev (CGTTTGAGGGGCCGCT
TTCTCCTTTGCTAATGGTAACTT)
Sigma-Aldrich N/A
Recombinant DNA
pGEX-3x-BOD1L F1 (aa 1-600 of BOD1L) This paper N/A
pGEX-3x-BOD1L F2 (aa 500-1000 of BOD1L) This paper N/A
pSNAPm-H3.1 Genevie`ve Almouzni; Adam et al., 2013 N/A
Software and Algorithms
ImageJ NIH RRID: SCR_003070
David Bioinformatics Resources 6.8 NIAID/NIH https://david.ncifcrf.gov/;
RRID: SCR_001881
Nikon Elements (v.4.5) Nikon RRID: SCR_014329
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U-2-OS-GFP-RAD51 cells was described in Sato et al. (2016). HeLa and U-2-OS cells used for FRAP analysis were cultured in Dul-
becco’smodified Eagle’s medium (HighGlucose; Nacalai Tesque), supplementedwith 10% fetal bovine serum (JRHBioscience) and
penicillin/streptomycin.
Wild-type and FANCD2mutant DT40 cell lines are described in Sato et al. (2012) andwere cultured in RPMImedium supplemented
with 10% FCS, 1% chicken serum (Sigma Aldrich) and 10 mM b-mercaptoethanol (Life Technologies).
METHOD DETAILS
siRNA Transfections
siRNAs were purchased from Dharmacon as SMARTpool, and all siRNA transfections were performed with 100 nM of siRNA du-
plexes using Oligofectamine (Life Technologies) or Lipofectamine2000 (Life Technologies). Whenever siRNAs were combined, the
total concentration was kept at 100 nM. An siRNA targeting lacZ (CGUACGCGGAAUACUUCGdTdT) or Negative Control Hi GC
(Life Technologies; for GFP-RAD51 analysis) was used as ‘‘Control siRNA.’’ SETD1A 30 UTR siRNA was from QIAGEN. See
Key Resources Table for siRNA sequences.
Drugs and Inhibitors
HU and MMCwere from Sigma Aldrich, and were used as indicated in Figure Legends. dNTP analogs EdU, CldU and IdU were from
Sigma Aldrich, and were used as denoted. Thymidine was from Sigma Aldrich. Mirin (100 mM) was from Calbiochem, and C5 (DNA2
inhibitor) (20 mM) was obtained from Judith Campbell (Liu et al., 2016).
Cloning
Constructs encoding pcDNA5/FRT-FLAG-SETD1A FL,DSET andDRRMvariants were obtained fromDavid Skalnik (Lee and Skalnik,
2005). pSNAPm-H3.1 was obtained from Genevie`ve Almouzni (Adam et al., 2013). Plasmids encoding WT or chaperone-dead
(R302W) mCherry-FANCD2 are described in Sato et al. (2012). GST-tagged BOD1L fragments were amplified by PCR from human
cDNA and cloned into the SalI-NotI restriction sites of pGEX-3X. Fragments 1 and 2 correspond to amino acids 1-600 and 500-1000
of BOD1L respectively. See Key Resources Table for primer sequences.
Colony Survival Assays
For colony survival assays, siRNA-transfected HeLa or HeLa-H3.1-GFP cells were plated at low density, and exposed to increasing
doses of MMC. Colonies were fixed and stained after 14 days with 2% methylene blue (Sigma Aldrich) in 50% ethanol. Data are ex-
pressed as a percentage survival normalized to non-treatment control for each siRNA.
DNA Fibers
DNA fibers were carried out as described previously (Higgs et al., 2015). For quantification of replication structures, cells were treated
with MMC (50 ng/ml) for 24 hr prior to analog labeling, and at least 250 structures were counted per experiment. For fork resection
experiments, cells were pulse-labeled with CldU and IdU for 20 min each before a 5 hr exposure to 4 mM HU, and at least 200 repli-
cation forks were analyzed per experimental condition. For fork resection experiments in DT40 cells, cells were pulse-labeled as
above, spun down in media containing 4mMHU and then exposed to HU for 5 hr as above. The lengths of red or green labeled tracts
were measured using ImageJ (National Institutes of Health; https://imagej.nih.gov/ij/) and arbitrary length values were converted into
micrometers using the scale bars created by the microscope. Mean tract ratios, SEM values and statistical analyses for all DNA fiber
analysis can be found in Table S1.
iPOND
iPOND was performed on HEK293T cells as described (Dungrawala et al., 2015). Briefly, light and heavy labeled cells were pulse-
labeled with EdU, incubated with 3 mM HU for 4 hr where indicated, mixed prior to the click reaction, and DNA-protein complexes
were captured with streptavidin-coupled beads. Samples were separated by SDS-PAGE, excised, reduced with DTT and carbami-
domethylated, and then destained. Polypeptides were digested with trypsin and analyzed by mass spectrometry using a Q Exactive
mass spectrometer in conjunction with MaxQuant. Plots are amalgamated from published log2 abundance data for the conditions
denoted.
Proximity Ligation Assay (PLA)
EdU-PLA to detect proteins at nascent DNA was performed as described (Taglialatela et al., 2017), with minor modifications. Briefly,
cells were pulsed with 10 mM EdU for 10 min cells before being permeabilised with nuclear extraction buffer (10 mM PIPES,
20 mMNaCl, 3 mMMgCl2, 300 mM sucrose, 0.5% Triton X-100). Where appropriate, cells were exposed to 4 mMHU for 5 hr before
pre-extraction. Cells were then fixed with 3.6% paraformaldehyde for 10 min at room temperature and blocked with ADB (Antibody
Dilution Buffer; 3% BSA in PBS) overnight at 4C. EdU was conjugated to biotin by incubating cells in Click reaction buffer for 1 hr at
room temperature containing 10 mMDiazo-biotin Azide, 10mM sodium ascorbate, and 1mM copper (II) sulfate in PBS. Following the
Click reaction, cells were blocked in ABD before incubated in primary antibodies before proceeding with proximity ligation using a
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Duolink Detection Kit in combination with anti-Mouse PLUS and anti-Rabbit MINUS PLA Probes (Sigma Aldrich) according to the
manufacturer’s instructions. Cells were imaged as below and the number of PLA signals per nuclei quantified.
Flow Cytometry
HeLa cells were harvested, fixed in 70%ethanol at20C for 1 hr, and permeabilised with 0.25%Triton X-100 for 15min at 4C. Cells
were then washed twice with 1%BSA in PBS, and stained with 25 mg/ml propidium iodide containing 0.1 mg/ml RNase A. Cells were
analyzed using an Accuri flow cytometer (BDBiosciences) in conjunction with CFlowplus software. Data represent that obtained from
at least 30,000 cells.
Metaphase Spreads
Chromosomal aberrations and radial chromosomes were scored in Giemsa stained metaphase spreads. For chromosome aberra-
tions, demecolcine (Sigma) was added 3-4 hr prior to harvesting at a final concentration of 0.2 mg/ml. Cells were harvested by tryp-
sinization, subjected to hypotonic shock for 1 hr at 37C in 0.3 M sodium citrate and fixed in 3:1 methanol:acetic acid solution. Cells
were dropped onto acetic acid humidified slides, stained for 15min in Giemsa-modified (Sigma) solution (5% v/v in H2O) andwashed
in water for 5 min.
Immunofluorescence, Microscopy, and Image Analysis
HeLa, U-2-OS, HeLa-H3.1-GFP and U-2-OS-FLAG-SETD1A cells were grown on glass coverslips. Cells were washed with PBS
twice before fixation. In all cases, cells were permeabilised with nuclear extraction buffer for 5 min on ice prior to fixation in 3.6%
paraformaldehyde for 10 min at room temperature. After fixation, cells were washed with PBS three times and then blocked with
ADB for 1 hr at 4C. Cells were incubated with primary antibody (diluted in ADB) for 1 hr at room temperature, washed with PBS
and then counterstained with Alexa Fluor-conjugated secondary antibodies (diluted in ADB) for 1 hr at room temperature. Cells
were then washed twice with ADB and coverslips were mounted onto glass slides with Vectashield mounting agent containing
0.4 mg/ml DAPI (Vectashield). Images were taken using a Nikon Eclipse Ni microscope equipped with a 60X oil lens, and were
acquired and analyzed using Elements v4.5 software (Nikon). For RPA intensity analyses, the intensity of nuclear foci was quantified
for each cell using ImageJ. See Key Resources Table for details of antibodies used.
SNAP Labeling of Histones
U-2-OS cells were grown on glass coverslips, transfected with siRNA, incubated for 48 hr, and transfected with pSNAPm-H3.1 using
FuGene HD. 24 hr post DNA transfection, pre-existing SNAP-H3.1 was labeled with SNAP-cell 505 star (New England Biolabs) ac-
cording to themanufacturer’s instructions (‘pulse’). Alternatively, pre-existing H3.1 was quenched by incubating cells with SNAP-cell
Block (New England Biolabs), and then cells were pulsed as described above (‘quench-pulse’), or released into 2 mM HU for 2 hr
before newly synthesized SNAP-H3.1 was labeled as above (‘quench-HU-pulse’). In all cases, cells were fixed with ice coldmethanol
for 10 min before being mounted onto glass slides. Images were taken as above, and the intensity of nuclear SNAP signal was quan-
tified for each cell using ImageJ.
Fluorescence Recovery after Photobleaching (FRAP)
FRAP was performed as previously described (Sato et al., 2012, 2016). HeLa cells expressing both H3.1-GFP and mCherry-PCNA
were grown on a glass-bottom dish (Mat-tek), transfected with siRNA, incubated for 48 h, and treated with MMC (50 ng/ml) for
12-24 hr. FRAP was then performed using an FV-1000 with a PlanApoN 60x OSC (NA = 1.4) oil-immersion objective lens (Olympus)
at 37C under 5% CO2. Three confocal images were collected (800x800 pixels, zoom 2, scan speed 2 ms/pixel, Kalman filtration for
four scans, pinhole 800 mm, 0.1% 488-nm laser transmission, and 20%543-nm laser transmission). Afterward, one half of PCNA-foci
positive nucleus was bleached using 75% transmission of 488 nm and 100% of 515 nm (three iterations), and images were obtained
using the original setting at 5 min intervals. The fluorescence intensities of the unbleached and bleached areas and background were
measured using ImageJ 1.46r software (https://imagej.nih.gov/ij/). After background subtraction, the relative intensity of the
bleached area to the unbleached area in each time point was calculated and normalized to the average intensity before bleaching.
H3.1-GFP K4A was analyzed by the same procedure with or without mitomycin C (50 ng/ml).
For GFP-RAD51 FRAP, U-2-OS cells expressing GFP-RAD51 were grown on a glass-bottom dish, transfected with siRNA, incu-
bated for 24 hr, and transfected with either the RNAi-resistant mCherry-FANCD2 or mCherry-FANCD2 (R302W) vector using FuGene
HD. The next day, cells were then treated with doxycycline (1-10 ng/ml) and MMC (100 ng/ml) for 12-24 hr, as described previously
(Sato et al., 2016). FRAP was then performed using an FV-1000 confocal microscopy with a PlanApoN 60x OSC (NA = 1.4) oil-im-
mersion objective lens (Olympus) at 37C under 5% CO2. Six z-slice images (0.5 mm intervals) containing GFP-RAD51 foci were
collected (2563 32 pixels, scan speed 2 ms/pixel, zoom 12, pinhole 800 mm, 0.1% 488-nm laser transmission, and 20%543-nm laser
transmission). Afterward, a single GFP-RAD51 focus was photobleached using 100% transmission of 488-nm laser (1 iteration for
each z-plane), and images were collected using the original settings at 1.89 s intervals for 100 s. The 2D maximum z-projection
was reconstructed, and the fluorescence intensities of the bleached area were measured using ImageJ 1.46r software. After the
background subtraction, the intensity was normalized to the initial intensity before bleaching.
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Western Blotting, Pull-downs, and Immunoprecipitations
For western blotting, whole cell extracts were obtained by lysis in UTB buffer (8 M Urea, 50 mM Tris, 150 mM b-mercaptoethanol,
protease inhibitor cocktail (Roche)). Cell extracts were sonicated, clarified by centrifugation, and protein concentration was
determined by Bradford Assay (Bio-Rad). Polypeptides were separated by SDS-PAGE, transferred onto nitrocellulose membrane,
incubated with primary antibody overnight, followed by HRP-linked secondary antibody for 1hr at room temperature. The signal
was detected using ECL western blotting substrate (GE Healthcare).
For immunoprecipitations, HeLa nuclear cells extracts (Cilbiotech) were clarified by centrifugation at 44,000 x g, immunoprecip-
itated with 5 mg of the indicated antibody or IgG for 3 hr at 4C. After further clarification, immune complexes were isolated using
protein-A Sepharose (GE Healthcare), and analyzed by immunoblotting as above.
For GST pull-downs, 1 mg of affinity-purified GST or GST fusion protein was incubated with pre-clarified HeLa nuclear cells extract
for 3 hr at 4C. Fusion proteins and binding partners were isolated using glutathione Sepharose (GE Healthcare) and analyzed as
above. See Key Resources Table for details of antibodies used.
For histone peptide pull-downs, lyophilized biotinylated peptides (Active Motif) were resuspended and immobilised onto Strepa-
vidin Agarose beads (Sigma Aldrich) as described inWysocka (2006) at a final concentration of 250 ng/ul. Immobilised peptides were
then incubated with clarified HeLa nuclear cells extracts for 3 hr at 4C before being washed with buffer D (100 mM KCl, 20 mM
HEPES pH 7.9, 20% v/v glycerol, 0.2 mM EDTA, 0.2% Triton X-100, protease inhibitors). Alternatively, immobilised peptides were
incubated with 100 ng of purified human FANCD2 (Sato et al., 2012; Takahashi et al., 2014) in binding buffer (20 mM Tris pH 7.5,
150 mM NaCl, 300 mM sucrose, 1 mM MgCl2, protease inhibitors) for 3 hr at 4
C. Bound protein was washed with buffer
D. In both cases, peptide binding partners were analyzed by immunoblotting as above.
For histone pull-downs, lyophilised recombinant biotinylated H3 or H3K4me1 (EPL) (Active Motif) were resuspended in
25 mM Tris pH 7.5, 150 mM NaCl, 5% glycerol at a final concentration of 1 mg/ul, and then incubated with 100 ng of purified human
FANCD2 in binding buffer for 3 hr at 4C. Histones were isolated with Strepavidin Agarose beads for a further 3 hr at 4C, washed as
above and analyzed by immunoblotting.
QUANTIFICATION AND STATISTICAL ANALYSIS
Differences in survival assays were analyzed by two-way ANOVA. Statistical differences in all other cases were determined by
Student’s t test, except for fork asymmetry, fork resection and EdU-PLA data, which were analyzed by Mann-Whitney rank sum
test. Statistical differences denoted in the Figures were determined by comparison to the relevant control-treated samples unless
otherwise indicated. In all cases: * = p < 0.05; ** = p < 0.01; *** = p < 0.001.
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